Exome sequencing and targeted gene panels: a simulated comparison of diagnostic yield using data from 158 patients with rare diseases

Caio Robledo D’Angioli Costa Quaio(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Chong Ae Kim(AstraZeneca (United States)), Sandro Félix Perazzio(Fleury S.A. (Brazil)), Christine Hsiaoyun Chung(Fleury S.A. (Brazil)), Gustavo Marquezani Spolador(Fleury S.A. (Brazil)), Vívian Pedigone Cintra(Fleury S.A. (Brazil)), Elisa Napolitano Ferreira(AC Camargo Hospital), Caroline Olivati(Fleury S.A. (Brazil)), Gil Monteiro Novo Filho(Fleury S.A. (Brazil)), Alexandre Ricardo dos Santos Fornari(Fleury S.A. (Brazil)), Caroline Mônaco Moreira(Fleury S.A. (Brazil)), Rodrigo Fernandes Ramalho(Fleury S.A. (Brazil)), María José Rivadeneira Obando(Universidade de São Paulo), Patricia Rossi Sacramento‐Bobotis(Fleury S.A. (Brazil)), Matheus Carvalho Bürger(Fleury S.A. (Brazil)), Aurélio Pimenta Dutra(Fleury S.A. (Brazil)), Michele Groenner Penna(Fleury S.A. (Brazil)), Wagner Antonio da Rosa Baratela(Fleury S.A. (Brazil)), Miguel Mitne‐Neto(Hospital Santa Paula), Rafaela Rogerio Floriano de Souza(Fleury S.A. (Brazil)), Otavio Jose Eulalio Pereira(Fleury S.A. (Brazil)), Rafael Alves da Silva(Fleury S.A. (Brazil)), Maria Carolina Pintão, Daniele Paixão(Fleury S.A. (Brazil)), Monize Nakamoto Provisor Santos(Fleury S.A. (Brazil)), Juliana Emilia Prior Carnavalli(Fleury S.A. (Brazil))
Figshare
January 1, 2022
Cited by 0


Related Papers